502 related articles for article (PubMed ID: 35994940)
1. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
2. The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.
Trickey A; Croxford S; Emanuel E; Ijaz S; Hickman M; Kesten J; Thomas C; Edmundson C; Desai M; Vickerman P
Clin Infect Dis; 2022 Sep; 75(6):1073-1077. PubMed ID: 35184173
[TBL] [Abstract][Full Text] [Related]
3. Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.
Trickey A; May MT; Hope V; Ward Z; Desai M; Heinsbroek E; Hickman M; Vickerman P
Drug Alcohol Depend; 2018 Nov; 192():118-124. PubMed ID: 30245460
[TBL] [Abstract][Full Text] [Related]
4. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.
Cullen KJ; Hope VD; Croxford S; Shute J; Ncube F; Parry JV
Epidemiol Infect; 2015 May; 143(7):1398-407. PubMed ID: 25119383
[TBL] [Abstract][Full Text] [Related]
6. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
[TBL] [Abstract][Full Text] [Related]
7. Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016.
Heinsbroek E; Glass R; Edmundson C; Hope V; Desai M
Int J Drug Policy; 2018 May; 55():215-221. PubMed ID: 29523484
[TBL] [Abstract][Full Text] [Related]
8. Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016-2017.
Maisa A; Semple S; Griffiths A; Ngui SL; Verlander NQ; McCaughey C; Doherty L; Jessop L;
J Viral Hepat; 2019 Dec; 26(12):1377-1387. PubMed ID: 31328838
[TBL] [Abstract][Full Text] [Related]
9. Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
Croxford S; Emanuel E; Ibitoye A; Njoroge J; Edmundson C; Bardsley M; Heinsbroek E; Hope V; Phipps E
Public Health; 2021 Mar; 192():8-11. PubMed ID: 33601307
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.
Ozga JE; Syvertsen JL; Pollini RA
J Viral Hepat; 2022 Jul; 29(7):518-528. PubMed ID: 35357738
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
Hope VD; Harris RJ; Vickerman P; Platt L; Shute J; Cullen KJ; Ijaz S; Mandal S; Ncube F; Desai M; Parry JV
Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
[TBL] [Abstract][Full Text] [Related]
12. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
13. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
[TBL] [Abstract][Full Text] [Related]
14. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs.
Trayner KMA; McAuley A; Palmateer NE; Goldberg DJ; Shepherd SJ; Gunson RN; Tweed EJ; Priyadarshi S; Milosevic C; Hutchinson SJ
Int J Drug Policy; 2020 Mar; 77():102663. PubMed ID: 31981949
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
Khezri M; Mirzazadeh A; Shokoohi M; Sharafi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mousavian G; Imani M; Kakavand-Ghalehnoei R; Komasi A; Gouya MM; Haghdoost AA; McFarland W; Karamouzian M; Sharifi H
Drug Alcohol Depend; 2023 Feb; 243():109751. PubMed ID: 36621200
[TBL] [Abstract][Full Text] [Related]
17. Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern Ireland.
Spring C; Croxford S; Ward Z; Ayres R; Lord C; Desai M; Emanuel E; Vickerman P; Artenie A
Int J Drug Policy; 2022 Apr; 102():103615. PubMed ID: 35172254
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
19. Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?
Gliddon HD; Ward Z; Heinsbroek E; Croxford S; Edmundson C; Hope VD; Simmons R; Mitchell H; Hickman M; Vickerman P; Stone J
Int J Drug Policy; 2024 Jan; ():104324. PubMed ID: 38218700
[TBL] [Abstract][Full Text] [Related]
20. The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.
Bardsley M; Heinsbroek E; Harris R; Croxford S; Edmundson C; Hope V; Hassan N; Ijaz S; Mandal S; Shute J; Hutchinson SJ; Hickman M; Sinka K; Phipps E
J Viral Hepat; 2021 Oct; 28(10):1452-1463. PubMed ID: 34270172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
